Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Nov;25(44):2001854.
doi: 10.2807/1560-7917.ES.2020.25.44.2001854.

The cat is out of the bag - point-of-care testing (POCT) is here to stay

Nick Phin  1   2 , Susan M Poutanen  3   4
Affiliations
Editorial

The cat is out of the bag - point-of-care testing (POCT) is here to stay

Nick Phin et al. Euro Surveill. 2020 Nov.
No abstract available

Keywords: laboratory surveillance; patient management; point-of-care testing; public health; sensitivity; specificity.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Nick Phin has no declared conflict of interests. Susan M Poutanen reports having received honoraria from Merck related to advisory boards and talks, honoraria from Verity, Cipher, and Paladin Labs related to advisory boards, partial conference travel reimbursement from Copan, and research support from Accelerate Diagnostics and bioMérieux, all outside the submitted work.

References

    1. Fernàndez-López L, Reyes-Urueña J, Conway A, Saz J, Morales A, Quezadas J, et al. The contribution of HIV point-of-care tests in early HIV diagnosis: community-based HIV testing monitoring in Catalonia, 1995 to 2018. Euro Surveill. 2020;25(43):1900424. 10.2807/1560-7917.ES.2020.25.43.1900424 - DOI - PMC - PubMed
    1. Celma CC, Beard S, Douglas A, Wong S, Osafo NK, Hannah M, et al. Retrospective analysis on confirmation rates for referred positive rotavirus samples in England, 2016 to 2017: implications for diagnosis and surveillance. Euro Surveill. 2020;25(43):1900375. 10.2807/1560-7917.ES.2020.25.43.1900375 - DOI - PMC - PubMed
    1. Vegvari C, Grad YH, White PJ, Didelot X, Whittles LK, Scangarella-Oman NE, et al. Using rapid point-of-care tests to inform antibiotic choice to mitigate drug resistance in gonorrhoea. Euro Surveill. 2020;25(43):1900210. 10.2807/1560-7917.ES.2020.25.43.1900210 - DOI - PMC - PubMed
    1. Harding-Esch EM, Huntington SE, Harvey MJ, Weston G, Broad CE, Adams EJ, et al. Antimicrobial resistance point-of-care testing for gonorrhoea treatment regimens: cost-effectiveness and impact on ceftriaxone use of five hypothetical strategies compared with standard care in England sexual health clinics. Euro Surveill. 2020;25(43):1900402. 10.2807/1560-7917.ES.2020.25.43.1900402 - DOI - PMC - PubMed
    1. Eley CV, Sharma A, Lee H, Charlett A, Owens R, McNulty CAM. Effects of primary care C-reactive protein point-of-care testing on antibiotic prescribing by general practice staff: pragmatic randomised controlled trial, England, 2016 and 2017. Euro Surveill. 2020;25(44):1900408 10.2807/1560-7917.ES.2020.25.44.1900408 - DOI - PMC - PubMed

Publication types

LinkOut - more resources